James Allison and Robert Schreiber won the Balzan Prize for their contributions to immunological approaches in cancer therapy. According to the prize committee, “Professors Schreiber and Allison have played transformative roles in the field of tumor immunology, Schreiber by demonstrating that the immune system is crucially involved in fighting tumours and by introducing the concept...
Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.
